BPC 157 is not FDA approved to treat ulcerative colitis, Crohn's disease, IBS, or any other medical condition in humans
Welcome back
Here is what the research actually shows, what a realistic transformation timeline looks like, and why GHK-Cu deserves its reputation as the gold standard of skin repair
Ages 30 to 50: Active Skin Support At this age, changes in the skins texture and overall tone become more noticeable
Retatrutides Phase 2 monotherapy weight loss (~24.2% at 48 weeks) is numerically larger than cagrilintides (~10.8% at 26 weeks), but those come from different trials, durations, and doses, and cagrilintides strongest data are as the CagriSema combination
If youre uncomfortable with self-injection, you can arrange to have a nurse or health professional administer it at an office or clinic